Alpha-1 Foundation

Total investments

1

Average round size

1M

Portfolio companies

1

Rounds per year

0.04

Lead investments

1

Areas of investment
BiotechnologyHealth CareLife SciencePharmaceutical

Summary

Alpha-1 Foundation appeared to be the Corporate Investor, which was created in 1995. The venture was found in North America in United States. The main department of described Corporate Investor is located in the Coral Gables.

The standard case for the fund is to invest in rounds with 2 partakers. The meaningful sponsors for the fund in investment in the same round are Edward Krapels. In the next rounds fund is usually obtained by Morningside Group, ALS Investment Fund.

Among the various public portfolio startups of the fund, we may underline Apic Bio Among the most popular fund investment industries, there are Life Science, Health Care. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.

The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2017. The common things for fund are deals in the range of 1 - 5 millions dollars.

Show more

Investments analytics

Analytics

Total investments
1
Lead investments
1
Rounds per year
0.04
Investments by industry
  • Biotechnology (1)
  • Pharmaceutical (1)
  • Life Science (1)
  • Health Care (1)
Investments by region
  • United States (1)
Peak activity year
2017

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
4

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Apic Bio 23 Aug 2017 Biotechnology, Health Care, Life Science, Pharmaceutical Seed 1M United States, Cambridge, Massachusetts
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.